Latest filing published 23 Mar 2023 for 易瑞生物.
付辉: trading record in brief
付辉 is a declared insider of 易瑞生物 (chief executive), with filings sourced from SSE / SZSE (CSRC). We count 3 filings; the first trade dates from 27 September 2022 and the latest from 23 March 2023.
No open-market purchase appears, only 3 sales worth €3.7M. 2023 to date brings no purchases and 1 sale.
Most recently, on 23 March 2023, the filings show an open-market sale worth €3.6M in 易瑞生物. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Companies and markets linked to 付辉
Open company profiles for insider transactions, fundamentals and analyst consensus when available.